Diurnal Variation in CSF Orexin-A in Healthy Male Subjects

Open Access
Publisher Website
Google Scholar
Abstract
Orexin-A is hypothesized to promote wakefulness, and we examined whether cerebrospinal fluid (CSF) orexin-A levels are higher during the waking period in man. Within-subjects, repeated-measures design with balanced ordering of sampling at approximately 5 AM and 5 PM. Eight healthy young males. CSF orexin-A levels and standard polysomnography. Orexin-A levels during the sleep period were 4% higher than during the waking period (314.9 pg/ml versus 302.8 pg/ml, p <0.03). Sleep period orexin-A levels were negatively correlated with REM sleep as a percentage of total sleep time (p <0.05). The day and night levels of orexin-A were strongly correlated within subjects (r = 0.97; p < 0.0001) even though the samples were collected 1–2 weeks apart. Orexin-A levels in lumbar CSF are slightly higher at 5 AM than at 5 PM. Because orexin release is thought to be highest during the waking period, this observation was unexpected and may reflect a long delay between the release of orexin and its appearance in lumbar CSF. Orexin-A levels vary moderately between subjects, but are quite consistent within the same subject. Thus, for the diagnostic evaluation of narcolepsy, the time of CSF collection should have little impact.

This publication has 0 references indexed in Scilit: